{
    "code": "13006029",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=13006029",
    "time": "2020-02-26 02:55:52",
    "許可證字號": "內衛藥輸字第006029號",
    "註銷狀態": "已註銷",
    "註銷日期": "74\/08\/31",
    "註銷理由": "內政部許可證展延",
    "製造許可登錄編號": "",
    "有效日期": "74\/07\/30",
    "發證日期": "59\/07\/30",
    "許可證種類": "製　劑",
    "舊證字號": "17012734",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01300602902",
    "中文品名": "可利斯Ｊ－Ｍ１００萬單位注射劑",
    "英文品名": "COLISTIN-M (FOR INJECTION) 1,000,000 UNITS",
    "適應症": "百日咳、大腸菌感染症：膀胱炎、腹膜炎、腎盂炎、因革蘭氏陰性菌引起之腸疾患：赤痢、傷寒、副傷寒、腸炎、綠膿菌混合感染症、尿路感染症、腹部之手術後之感染",
    "劑型": "240乾粉注射劑",
    "包裝": "小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "COLISTIN SODIUM METHANESULFONATE (COLISTIMETHATE SOD.), DIBUCAINE HCL",
    "限制項目": "02輸　入",
    "申請商名稱": "0907001100  恆通行股份有限公司",
    "申請商地址": "台北巿重慶南路一段１１１號",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0018000  BANYU PHARMACEUTICAL CO. LTD.",
            "製造廠廠址": "2-3, 2-CHOME, NIHONBASHI HONCHO, CHUO-KU TOKYO 103",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812000320",
            "成分名稱": "COLISTIN SODIUM METHANESULFONATE (COLISTIMETHATE SOD.)",
            "含量描述": "1000000",
            "含量": "1000000.0000000000",
            "單位": "U (UN"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "7200000510",
            "成分名稱": "DIBUCAINE HCL",
            "含量描述": "2",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ]
}